Immunotherapy

Cancer cell therapy pioneer Carl June receives the Sanford Lorraine Cross Award

The Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine and director of the Center for Cellular Immunotherapies at Penn’s Abramson Cancer Center received the award for his work in developing chimeric antigen receptor (CAR) T cell therapy.

Steve Graff

Avery Posey’s cancer research takes high risks for big rewards

The assistant professor of systems pharmacology and translational therapeutics, who studied with Carl June as a postdoctoral fellow, combines his two research passions—gene therapy and investigating ‘little known’ biology—in the pursuit of new knowledge.

From Penn Medicine News

Navigating cytokine storms

Pairing their expertise, Nilam Mangalmurti of the Perelman School of Medicine and Christopher Hunter of the School of Veterinary Medicine have been working to understand the protective and harmful aspects of the immune response, including in COVID-19.

Katherine Unger Baillie



In the News


Philadelphia Inquirer

Penn immunotherapy pioneer Carl June shares prize from Israeli foundation that also honors Fauci

Carl June of the Perelman School of Medicine was awarded a Dan David prize for his contributions to immunotherapy.

FULL STORY →



The New York Times

A woman may have been cured of HIV without medical treatment

Una O’Doherty of the Perelman School of Medicine commented on a study that appeared to fully suppress HIV without using drugs. “It’s certainly encouraging but speculative,” she said. “I need to see more before I would say, ‘Oh, she’s cured.’”

FULL STORY →



The New York Times

Decades-old Soviet studies hint at coronavirus strategy

Paul Offit of the Perelman School of Medicine said the benefits of a repurposed vaccines are limited. “We are much better off with a vaccine that induces specific immunity,” he said.

FULL STORY →